Table 1.
Baseline Clinical Characteristics
| Variable | High‐CRP Groupa (n = 54) | Normal‐CRP Groupb (n = 70) | P Value |
|---|---|---|---|
| Age, y | 62 ± 9 | 58 ± 9 | 0.017 |
| Male sex, n (%) | 30 (56) | 53 (76) | 0.022 |
| HT, n (%) | 24 (44) | 41 (59) | 0.118 |
| DM, n (%) | 17 (32) | 23 (33) | 0.871 |
| Dyslipidemia, n (%) | 17 (32) | 27 (39) | 0.413 |
| Current smoker, n (%) | 18 (33) | 17 (24) | 0.275 |
| Previous MI, n (%) | 1 (2) | 4 (6) | 0.381 |
| Clinical presentation, n (%) | 0.015 | ||
| SA | 29 (54) | 49 (70) | |
| ACS | 25 (46) | 21 (30) | |
| UA | 4 (7) | 4 (6) | |
| NSTEMI | 6 (11) | 7 (10) | |
| STEMI | 15 (28) | 10 (14) | |
| Medications at index procedure, n (%) | |||
| Aspirin | 54 (100) | 69 (99) | 0.825 |
| Clopidogrel | 56 (100) | 70 (100) | 1.000 |
| β‐Blocker | 46 (87) | 55 (79) | 0.239 |
| ACEI or ARB | 38 (70) | 49 (71) | 0.938 |
| Statin | 52 (96) | 67 (96) | 0.813 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin receptor blocker; DM, diabetes mellitus; hs‐CRP, high‐sensitivity C‐reactive protein; HT, hypertension; MI, myocardial infarction; NA, not applicable; NSTEMI, non–ST‐elevation myocardial infarction; SA, stable angina; STEMI, ST‐elevation myocardial infarction; UA, unstable angina.
a
Hs‐CRP ≥3 mg/L.
b
Hs‐CRP <3 mg/L.